No results for ‘’
Advanced Enzyme Technologies Ltd
₹293.40
(3.28%)
Tue, 15 Sept 2026, 01:44 am
Consumer Non-Durables
Food: Specialty/Candy
24.5KAdvanced Enzyme Technologies Enterprise Value (EV)
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.82 | 26.43 | 18.40 | 12.38 | 26.44 | 26.39 | 24.52 | 29.16 | 23.82 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.91 | 4.25 | 3.01 | 1.90 | 3.97 | 2.90 | 2.10 | 2.93 | 2.20 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.88 | 6.13 | 4.95 | 3.62 | 7.71 | 5.97 | 4.79 | 6.24 | 4.91 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.64 | 21.30 | 16.34 | 11.01 | 23.76 | 25.92 | 17.76 | 25.68 | 20.95 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4629Cr | 2407Cr | 1970Cr | 1455Cr | 3628Cr | 2867Cr | 2190Cr | 3436Cr | 2618Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.20 | 14.83 | 10.77 | 7.18 | 15.47 | 13.92 | 13.30 | 16.57 | 13.27 |
| Debt to equity ratio | 1.23 | 0.93 | 0.75 | 1.03 | 2.13 | 1.13 | 1 | 0.54 | 0.37 | 0.12 | 0.12 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
| Return on equity % | 0 | 20.24 | 26.86 | 29.97 | 42.40 | 38.26 | 11.93 | 26.87 | 30.95 | 24.67 | 17.67 | 17.94 | 17.03 | 16.12 | 11.61 | 9.09 | 10.42 | 9.55 |
Advanced Enzyme Technologies Ltd Enterprise Value
The Advanced Enzyme Technologies Ltd Enterprise Value is a key financial metric used by investors to evaluate Advanced Enzyme Technologies Ltd's valuation, profitability, and overall financial performance. Tracking the Advanced Enzyme Technologies Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Advanced Enzyme Technologies Ltd (NSE: ADVENZYMES, BSE: 540025) is currently trading at ₹293.40, with a market capitalization of ₹3394.56Cr. As a leading company in the Consumer non-durables sector and Food: specialty/candy industry, monitoring the Advanced Enzyme Technologies Ltd Enterprise Value is essential for fundamental analysis.
Advanced Enzyme Technologies Ltd Enterprise Value Current Value
The current Advanced Enzyme Technologies Ltd Enterprise Value stands at 2618Cr.
The Advanced Enzyme Technologies Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Advanced Enzyme Technologies Ltd Enterprise Value Historical Trend
The Advanced Enzyme Technologies Ltd Enterprise Value has shown the following historical trend:
- 2024: 2618Cr
- 2023: 3436Cr
- 2022: 2190Cr
- 2021: 2867Cr
- 2020: 3628Cr
The decline in Advanced Enzyme Technologies Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Advanced Enzyme Technologies Ltd Enterprise Value Indicates for Investors
The Advanced Enzyme Technologies Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Advanced Enzyme Technologies Ltd.
Advanced Enzyme Technologies Ltd Enterprise Value Analysis Summary
The Advanced Enzyme Technologies Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Advanced Enzyme Technologies Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Advanced Enzyme Technologies Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.